Non Fungible Human

Cardiologist Dr. James Min, founder of Cleerly, explains why most heart attacks strike without warning and how AI-powered plaque imaging could catch heart disease years before it's too late. We dig into why cholesterol alone misses so many patients and what it takes to go upstream on the world's number one killer.

Half of patients don't take their medications as prescribed, and years of apps and reminders haven't closed the gap. Kempton Presley, CEO of AdhereHealth, joins to explain why the fix isn't more technology. It's using data to find who's at risk and why, so a human can step in at the right moment. We have a discussion on adherence, burnout, and the part of care you can't automate.

In this conversation, Warren Templeton, managing director of Health 2047, discusses the role of the American Medical Association's venture studio in supporting healthcare startups. He explains the investment process, the importance of problem definition, and the evaluation criteria for startups.

Dr. Natalia Chalmers has seen the dental system from every side: FDA dental officer, first-ever Chief Dental Officer at CMS, and now Head of Clinical Innovation at Overjet, the world's largest dental AI company. She's also a pediatric dentist and the 2025 Pediatric Dentist of the Year.

In this episode, we discuss the tragedy that changed her career, how the right data in front of the right legislators won dental coverage for 800,000 adults in Maryland, and what FDA-cleared AI is actually doing in the dental chair today. We break down how the technology works, why the provider always owns the diagnosis, the role of AI in preauthorization battles between providers and payers, and her vision for a common language between dentistry and medicine.

Whether you're a clinician, a policy nerd, or just someone who's ever gotten two different opinions from two different dentists, this one's for you.

What does it actually take to move a healthcare idea from a pitch deck to the bedside? In this episode, I sit down with Osama Alsaleh, Head of Partnerships at Plug and Play Health, to unpack how one of the world's most active innovation platforms decides which startups to back and how AI is reshaping the way care gets delivered. We get into what separates hype from real clinical value, how venture capital is flowing into health tech right now, and where Osama sees the biggest opportunities (and the biggest blind spots) for founders building in this space. If you're curious about the engine behind healthcare innovation, this one's for you.

Exploring the transformative potential of agentic AI in healthcare with Dr. David Carmouche of Lumeris, focusing on primary care innovation, data integration, and future payment models.

Dr. Owais Durrani sits down with Dr. Amanda Heidemann from UpToDate to talk AI, clinical decision support, and what the future of medical knowledge actually looks like at the bedside.

At ViVE, I sat down with Dr. Amit Phull, Chief Clinical Experience Officer at Doximity, to talk about the rapidly evolving AI landscape in healthcare.

We discuss tools like DoximityGPT, what clinicians actually need from AI, and where things may be headed over the next year.

A conversation about turning AI hype into real clinical workflow impact.

BloodGPT CEO Jonathan Kron joins the podcast to discuss how AI is transforming lab results, improving patient understanding, and supporting clinicians without replacing them.

What does real healthcare innovation look like inside a major academic medical center?

Dr. Owais Durrani is joined by Roberta Schwartz, Executive Vice President and Chief Innovation Officer at Houston Methodist, for a candid conversation about how innovation actually works at scale. They discuss virtual nursing, imaging AI, ambient documentation, and how health systems decide which technologies are worth investing in and which ones aren’t.

A practical look at improving patient care and moving healthcare forward beyond the hype.